Author of the publication

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease.

, , , , , , , and . BMC Medical Informatics Decis. Mak., 20 (1): 288 (2020)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Danaei, Goodarz
add a person with the name Danaei, Goodarz
 

Other publications of authors with the same name

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease., , , , , , , and . BMC Medical Informatics Decis. Mak., 20 (1): 288 (2020)Predicting Cardiovascular Disease Risk using Photoplethysmography and Deep Learning., , , , , , , , , and 6 other author(s). CoRR, (2023)Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010., , , , , , , , , and 351 other author(s). Lancet (London, England), 380 (9859): 2197--2223 (Dec 15, 2012)Target trial emulation: applying principles of randomised trials to observational studies, , , and . (2022)A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, , , , , , , , , and 199 other author(s). The Lancet, 380 (9859): 2224--2260 (Dec 15, 2012)Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins., , and . American journal of epidemiology, 175 (4): 250-62 (February 2012)6595<m:linebreak></m:linebreak>GR: R01 HL080644/HL/NHLBI NIH HHS/United States; JID: 7910653; 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); OID: NLM: PMC3271813 Available on 02/15/13; PMCR: 2013/02/15 00:00; 2012/01/05 aheadofprint; ppublish;<m:linebreak></m:linebreak>New-user designs; CER; Bias; CV.Handling time varying confounding in observational research, , , , and . BMJ, (October 2017)Anàlisi de dades; IPTW; G methods.